Florian Kronenberg - Genetic Mutations

Author Information

Florian Kronenberg is a distinguished researcher affiliated with the Institute of Genetic Epidemiology, Department of Genetics and Pharmacology, at the Medical University of Innsbruck in Austria. His work primarily focuses on genetic epidemiology, with a significant emphasis on genetic factors contributing to complex diseases, cardiovascular health, and kidney function.

Research Contributions

Florian Kronenberg has made substantial contributions to the field of genetics and epidemiology. His research has provided valuable insights into the genetic determinants of complex diseases, such as cardiovascular conditions and chronic kidney disease. Among his notable studies are investigations into the genetic factors associated with circulating uromodulin, the impact of hyperlipoprotein(a)emia on cardiovascular risk, and the role of PCSK9 in cardiovascular disease among individuals with reduced kidney function. His work also includes studies on the genetic basis of stroke, the influence of body mass index on respiratory function, and the associations between lipoprotein(a) levels and atherosclerotic plaque characteristics.

Aliases

F Kronenberg, F. Kronenberg, Florian Kronenberg

Publication and Citation Metrics

Metric	Value
Citation Count	43,336
H-index	100
Paper Count	606

Publications:

Genome-wide studies reveal factors associated with circulating uromodulin and its relations with complex diseases.

DOI: 10.1172/jci.insight.157035

Year: 2022

Genome-Wide Characterization of a Highly Penetrant Form of Hyperlipoprotein(a)emia Associated With Genetically Elevated Cardiovascular Risk

DOI: 10.1161/CIRCGEN.121.003489

Year: 2022

PCSK9 and Cardiovascular Disease in Individuals with Moderately Decreased Kidney Function.

DOI: 10.2215/CJN.01230122

Year: 2022

A Family and a Genome-Wide Polygenic Risk Score Are Independently Associated With Stroke in a Population-Based Study.

DOI: 10.1161/STROKEAHA.121.036551

Year: 2022

Heart-Type Fatty Acid Binding Protein, Cardiovascular Outcomes, and Death: Findings From the German CKD Cohort Study.

DOI: 10.1053/j.ajkd.2022.01.424

Year: 2022

Causal Effects of Body Mass Index on Airflow Obstruction and Forced Mid-Expiratory Flow: A Mendelian Randomization Study Taking Interactions and Age-Specific Instruments Into Consideration Toward a Life Course Perspective

DOI: 10.3389/fpubh.2021.584955

Year: 2021

Apolipoprotein A‐IV concentrations and clinical outcomes in a large chronic kidney disease cohort: Results from the GCKD study

DOI: 10.1111/joim.13437

Year: 2021

Author Correction: Rare genetic variants affecting urine metabolite levels link population variation to inborn errors of metabolism

DOI: 10.1038/s41467-021-26242-7

Year: 2021

Lipoprotein(a) levels and atherosclerotic plaque characteristics in the carotid artery: The Plaque at RISK (PARISK) study.

DOI: 10.1016/j.atherosclerosis.2021.06.004

Year: 2021

Measuring lipoprotein(a): do it without ifs and buts.

DOI: 10.1093/eurjpc/zwab180

Year: 2021

How Are These Errors Detected?

What Research is Being Done on Sickle Cell Anemia?

How are Autosomal Recessive Disorders Diagnosed?

How Does Gene Amplification Occur?

Why is Gene Cloning Important?

What Are the Future Directions in Sickle Cell Disease Research?

What Types of Genetic Mutations Can Be Treated?

What Challenges Exist in Using Genetic Information for Medication Management?

What Makes a Mutation Harmful?

What is Meiosis?

Partnered Content Networks

Relevant Topics